← FDA DRUG APPROVALS

FDA ANDA · ANDA200172

RANITIDINE HYDROCHLORIDE

Sponsor: APOTEX INC

APPLICATION
ANDA200172
TYPE
ANDA
ORIGINAL APPROVAL
2012-05-31
LATEST ACTION
2016-11-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

RANITIDINE HYDROCHLORIDEDiscontinued
RANITIDINE HYDROCHLORIDE EQ 150MG BASE · TABLET · ORAL

Approval history

2016-11-14Labeling · Supplement 5 · standardAP
2012-05-31Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →